A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis

Donato Rigante, A Ravelli, G Bracciolini, S Davì, A Pistorio, A Consolaro, S Verazza, B Lattanzi, G Filocamo, S Dalpra, M Gattinara, V Gerloni, A Insalaco, F De Benedetti, A Civino, L Breda, L Lepore, MC Maggio, F Garofalo, S Magni ManzoniA Buoncompagni, M Gattorno, C Malattia, S Viola, P Picco, N Ruperto, A. Martini

Research output: Contribution to journalArticle

Abstract

There is paucity of evidence-based information to guide treatment of oligoarticular juvenile idiopathic arthritis (JIA). We aimed to investigate whether combination with methotrexate increases the efficacy of intra-articular corticosteroid (IAC) therapy in patients with JIA. The report describes our preliminary experience in children aged 18 years or younger who were candidates to receive IAC in one to four joints. We randomly allocated a subgroup of patients via a computer-based system to IAC alone or in combination with methotrexate. Our primary outcome in intention to treat analysis was the proportion of patients achieving remission of synovitis in all injected joints at 12 months.
Original languageEnglish
Pages (from-to)127-128
Number of pages2
JournalARTHRITIS & RHEUMATOLOGY
Volume2014
Publication statusPublished - 2014

Keywords

  • Juvenile idiopathic arthritis

Fingerprint

Dive into the research topics of 'A controlled trial of intra-articular corticosteroids with or without methotrexate in oligoarticular juvenile idiopathic arthritis'. Together they form a unique fingerprint.

Cite this